These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antigen targeting to CD11b allows efficient presentation of CD4+ and CD8+ T cell epitopes and in vivo Th1-polarized T cell priming. Schlecht G, Loucka J, Najar H, Sebo P, Leclerc C. J Immunol; 2004 Nov 15; 173(10):6089-97. PubMed ID: 15528345 [Abstract] [Full Text] [Related]
6. Therapy of murine tumors with recombinant Bordetella pertussis adenylate cyclase carrying a cytotoxic T cell epitope. Fayolle C, Ladant D, Karimova G, Ullmann A, Leclerc C. J Immunol; 1999 Apr 01; 162(7):4157-62. PubMed ID: 10201941 [Abstract] [Full Text] [Related]
7. In vivo induction of CTL responses by recombinant adenylate cyclase of Bordetella pertussis carrying viral CD8+ T cell epitopes. Fayolle C, Sebo P, Ladant D, Ullmann A, Leclerc C. J Immunol; 1996 Jun 15; 156(12):4697-706. PubMed ID: 8648115 [Abstract] [Full Text] [Related]
8. Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis. Mascarell L, Fayolle C, Bauche C, Ladant D, Leclerc C. J Virol; 2005 Aug 15; 79(15):9872-84. PubMed ID: 16014948 [Abstract] [Full Text] [Related]
9. Novel breast-tumor-associated MUC1-derived peptides: characterization in Db-/- x beta2 microglobulin (beta2m) null mice transgenic for a chimeric HLA-A2.1/Db-beta2 microglobulin single chain. Carmon L, El-Shami KM, Paz A, Pascolo S, Tzehoval E, Tirosh B, Koren R, Feldman M, Fridkin M, Lemonnier FA, Eisenbach L. Int J Cancer; 2000 Feb 01; 85(3):391-7. PubMed ID: 10652432 [Abstract] [Full Text] [Related]
10. Antigen targeting to CD11b+ dendritic cells in association with TLR4/TRIF signaling promotes strong CD8+ T cell responses. Dadaglio G, Fayolle C, Zhang X, Ryffel B, Oberkampf M, Felix T, Hervas-Stubbs S, Osicka R, Sebo P, Ladant D, Leclerc C. J Immunol; 2014 Aug 15; 193(4):1787-98. PubMed ID: 25024388 [Abstract] [Full Text] [Related]
11. Immunization with a circumsporozoite epitope fused to Bordetella pertussis adenylate cyclase in conjunction with cytotoxic T-lymphocyte-associated antigen 4 blockade confers protection against Plasmodium berghei liver-stage malaria. Tartz S, Kamanova J, Simsova M, Sebo P, Bolte S, Heussler V, Fleischer B, Jacobs T. Infect Immun; 2006 Apr 15; 74(4):2277-85. PubMed ID: 16552058 [Abstract] [Full Text] [Related]
12. The adenylate cyclase toxin from Bordetella pertussis--a novel promising vehicle for antigen delivery to dendritic cells. Simsova M, Sebo P, Leclerc C. Int J Med Microbiol; 2004 Apr 15; 293(7-8):571-6. PubMed ID: 15149033 [Abstract] [Full Text] [Related]
13. Melanoma-reactive class I-restricted cytotoxic T cell clones are stimulated by dendritic cells loaded with synthetic peptides, but fail to respond to dendritic cells pulsed with melanoma-derived heat shock proteins in vitro. Fleischer K, Schmidt B, Kastenmüller W, Busch DH, Drexler I, Sutter G, Heike M, Peschel C, Bernhard H. J Immunol; 2004 Jan 01; 172(1):162-9. PubMed ID: 14688322 [Abstract] [Full Text] [Related]
14. Induction of a polarized Th1 response by insertion of multiple copies of a viral T-cell epitope into adenylate cyclase of Bordetella pertussis. Dadaglio G, Moukrim Z, Lo-Man R, Sheshko V, Sebo P, Leclerc C. Infect Immun; 2000 Jul 01; 68(7):3867-72. PubMed ID: 10858196 [Abstract] [Full Text] [Related]
15. HLA-A2.1/K(b) transgenic murine dendritic cells transduced with an adenovirus encoding human gp100 process the same A2.1-restricted peptide epitopes as human antigen-presenting cells and elicit A2.1-restricted peptide-specific CTL. Yang S, Linette GP, Longerich S, Roberts BL, Haluska FG. Cell Immunol; 2000 Aug 25; 204(1):29-37. PubMed ID: 11006015 [Abstract] [Full Text] [Related]
16. DNA fusion vaccines induce epitope-specific cytotoxic CD8(+) T cells against human leukemia-associated minor histocompatibility antigens. Rice J, Dunn S, Piper K, Buchan SL, Moss PA, Stevenson FK. Cancer Res; 2006 May 15; 66(10):5436-42. PubMed ID: 16707472 [Abstract] [Full Text] [Related]
17. In vivo receptor-mediated delivery of a recombinant invasive bacterial toxoid to CD11c + CD8 alpha -CD11bhigh dendritic cells. Guermonprez P, Fayolle C, Rojas MJ, Rescigno M, Ladant D, Leclerc C. Eur J Immunol; 2002 Nov 15; 32(11):3071-81. PubMed ID: 12385027 [Abstract] [Full Text] [Related]
18. Charge-dependent translocation of Bordetella pertussis adenylate cyclase toxin into eukaryotic cells: implication for the in vivo delivery of CD8(+) T cell epitopes into antigen-presenting cells. Karimova G, Fayolle C, Gmira S, Ullmann A, Leclerc C, Ladant D. Proc Natl Acad Sci U S A; 1998 Oct 13; 95(21):12532-7. PubMed ID: 9770520 [Abstract] [Full Text] [Related]
19. Derivation of HLA-A11/Kb transgenic mice: functional CTL repertoire and recognition of human A11-restricted CTL epitopes. Alexander J, Oseroff C, Sidney J, Wentworth P, Keogh E, Hermanson G, Chisari FV, Kubo RT, Grey HM, Sette A. J Immunol; 1997 Nov 15; 159(10):4753-61. PubMed ID: 9366399 [Abstract] [Full Text] [Related]
20. Dendritic cells pulsed with exogenous hepatitis B surface antigen particles efficiently present epitopes to MHC class I-restricted cytotoxic T cells. Stober D, Trobonjaca Z, Reimann J, Schirmbeck R. Eur J Immunol; 2002 Apr 15; 32(4):1099-108. PubMed ID: 11920577 [Abstract] [Full Text] [Related] Page: [Next] [New Search]